Literature DB >> 23474111

Assessment of interfraction patient setup for head-and-neck cancer intensity modulated radiation therapy using multiple computed tomography-based image guidance.

X Sharon Qi1, Angie Y Hu, Steve P Lee, Percy Lee, John DeMarco, X Allen Li, Michael L Steinberg, Patrick Kupelian, Daniel Low.   

Abstract

PURPOSE: Various image guidance systems are commonly used in conjunction with intensity modulated radiation therapy (IMRT) in head-and-neck cancer irradiation. The purpose of this study was to assess interfraction patient setup variations for 3 computed tomography (CT)-based on-board image guided radiation therapy (IGRT) modalities. METHODS AND MATERIALS: A total of 3302 CT scans for 117 patients, including 53 patients receiving megavoltage cone-beam CT (MVCBCT), 29 receiving kilovoltage cone-beam CT (KVCBCT), and 35 receiving megavoltage fan-beam CT (MVFBCT), were retrospectively analyzed. The daily variations in the mediolateral (ML), craniocaudal (CC), and anteroposterior (AP) dimensions were measured. The clinical target volume-to-planned target volume (CTV-to-PTV) margins were calculated using 2.5Σ + 0.7 σ, where Σ and σ were systematic and random positioning errors, respectively. Various patient characteristics for the MVCBCT group, including weight, weight loss, tumor location, and initial body mass index, were analyzed to determine their possible correlation with daily patient setup.
RESULTS: The average interfraction displacements (± standard deviation) in the ML, CC, and AP directions were 0.5 ± 1.5, -0.3 ± 2.0, and 0.3 ± 1.7 mm (KVCBCT); 0.2 ± 1.9, -0.2 ± 2.4, and 0.0 ± 1.7 mm (MVFBCT); and 0.0 ± 1.8, 0.5 ± 1.7, and 0.8 ± 3.0 mm (MVCBCT). The day-to-day random errors for KVCBCT, MVFBCT, and MVCBCT were 1.4-1.6, 1.7, and 2.0-2.1 mm. The interobserver variations were 0.8, 1.1, and 0.7 mm (MVCBCT); 0.5, 0.4, and 0.8 mm (MVFBCT); and 0.5, 0.4, and 0.6 mm (KVCBCT) in the ML, CC, and AP directions, respectively. The maximal calculated uniform CTV-to-PTV margins were 5.6, 6.9, and 8.9 mm for KVCBCT, MVFBCT, and MVCBCT, respectively. For the evaluated patient characteristics, the calculated margins for different patient parameters appeared to differ; analysis of variance (ANOVA) and/or t test analysis found no statistically significant setup difference in any direction.
CONCLUSIONS: Daily random setup errors and CTV-to-PTV margins for treatment of head-and-neck cancer were affected by imaging quality. Our data indicated that larger margins were associated with MVFBCT and MVCBCT, compared with smaller margins for KVCBCT. IGRT modalities with better image quality are encouraged in clinical practice.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23474111     DOI: 10.1016/j.ijrobp.2013.01.022

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  11 in total

1.  Clinical Development and Evaluation of Megavoltage Topogram for Fast Patient Alignment on Helical Tomotherapy.

Authors:  X Sharon Qi; Fang-I Chu; Zhe Zhang; Robert K Chin; Ann Raldow; Amar U Kishan; Percy Lee; Albert Chang; Anusha Kalbasi; Mitchell Kamrava; Michael L Steinberg; Daniel A Low
Journal:  Adv Radiat Oncol       Date:  2020-06-17

2.  A prospective analysis of inter- and intrafractional errors to calculate CTV to PTV margins in head and neck patients.

Authors:  J Cacicedo; J F Perez; R Ortiz de Zarate; O del Hoyo; F Casquero; A Gómez-Iturriaga; A Lasso; E Boveda; P Bilbao
Journal:  Clin Transl Oncol       Date:  2014-07-19       Impact factor: 3.405

3.  A pilot study of highly accelerated 3D MRI in the head and neck position verification for MR-guided radiotherapy.

Authors:  Yihang Zhou; Oi Lei Wong; Kin Yin Cheung; Siu Ki Yu; Jing Yuan
Journal:  Quant Imaging Med Surg       Date:  2019-07

4.  Human-level comparable control volume mapping with a deep unsupervised-learning model for image-guided radiation therapy.

Authors:  Xiaokun Liang; Maxime Bassenne; Dimitre H Hristov; Md Tauhidul Islam; Wei Zhao; Mengyu Jia; Zhicheng Zhang; Michael Gensheimer; Beth Beadle; Quynh Le; Lei Xing
Journal:  Comput Biol Med       Date:  2021-12-17       Impact factor: 4.589

5.  Setup errors in patients with head-neck cancer (HNC), treated using the Intensity Modulated Radiation Therapy (IMRT) technique: how it influences the customised immobilisation systems, patient's pain and anxiety.

Authors:  Massimiliano Contesini; Monica Guberti; Roberta Saccani; Luca Braglia; Cinzia Iotti; Andrea Botti; Emilio Abbati; Marina Iemmi
Journal:  Radiat Oncol       Date:  2017-04-27       Impact factor: 3.481

6.  Positional uncertainties of cervical and upper thoracic spine in stereotactic body radiotherapy with thermoplastic mask immobilization.

Authors:  Seung Hyuck Jeon; Jin Ho Kim
Journal:  Radiat Oncol J       Date:  2018-06-29

7.  Analysis of which local set-up errors can be covered by a 5-mm margin for cone beam CT-guided radiotherapy for nasopharyngeal carcinoma.

Authors:  Renming Zhong; Ying Song; Yuying Yan; Xuetao Wang; Shuai Li; Jidan Zhou; Xiaoyu Li; Sen Bai
Journal:  Br J Radiol       Date:  2018-05-17       Impact factor: 3.039

8.  Prospective assessment of inter- or intra-fractional variation according to body weight or volume change in patients with head and neck cancer undergoing radiotherapy.

Authors:  Seong Hoon Kim; Se An Oh; Ji Woon Yea; Jae Won Park
Journal:  PLoS One       Date:  2019-05-16       Impact factor: 3.240

9.  Assessment of positional reproducibility in the head and neck on a 1.5-T MR simulator for an offline MR-guided radiotherapy solution.

Authors:  Yihang Zhou; Jing Yuan; Oi Lei Wong; Winky Wing Ki Fung; Ka Fai Cheng; Kin Yin Cheung; Siu Ki Yu
Journal:  Quant Imaging Med Surg       Date:  2018-10

10.  Quantification and Assessment of Interfraction Setup Errors Based on Cone Beam CT and Determination of Safety Margins for Radiotherapy.

Authors:  Macarena Cubillos Mesías; Judit Boda-Heggemann; Johannes Thoelking; Frank Lohr; Frederik Wenz; Hansjoerg Wertz
Journal:  PLoS One       Date:  2016-03-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.